Search

Your search keyword '"Calverley, Peter"' showing total 1,531 results
Start Over Author "Calverley, Peter"
1,531 results on '"Calverley, Peter"'

62. International Differences in the Frequency of COPD Exacerbations Reported in Three Clinical Trials

Author

Calverley, Peter M.a., Martinez, Fernando J., Vestbo, Jørgen, Jenkins, Christine R., Wise, Robert, Lipson, David A., Cowans, Nicholas J., Yates, Julie, Crim, Courtney, and Celli, Bartolome R

Abstract

Rationale: Exacerbations of chronic obstructive pulmonary disease are an important endpoint in multinational clinical treatment trials, but the observed event rate is often lower than anticipated and appears to vary between countries. Objectives: We investigated whether systematic differences in national exacerbation rates might explain this observed variation. Methods: We reviewed data from three large multicenter international randomized trials conducted over an 18-year period with different designs and clinical severities of chronic obstructive pulmonary disease, comparing bronchodilator and/or inhaled corticosteroids with bronchodilators alone and/or placebo. Exacerbations were defined by antibiotic and/or oral corticosteroid use (moderate) or need for hospitalization (severe). We calculated crude exacerbation rates in the 30 countries contributing 30 or more patients to at least two trials. We grouped data by exacerbation rate based on their first study contribution. Measurements and Main Results: For the 29,756 patients in 41 countries analyzed, the mean exacerbation rate was 2–3-fold different between the highest and lowest tertiles of the recruiting nations. These differences were not explained by demographic features, study protocol, or reported exacerbation history at enrolment. Of the 18 countries contributing to all studies, half of those in the highest and half in the lowest tertiles of exacerbation history remained in these groups across studies. Severe exacerbations showed a different rank order internationally. Conclusions: Countries contributing to chronic obstructive pulmonary disease trials differ consistently in their reporting of health care-defined exacerbations. These differences help explain why large studies have been needed to show differences between treatments that decrease exacerbation risk.

Published
2022

63. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset

Author

Calverley,Peter MA, Papi,Alberto, Page,Clive, Rogliani,Paola, Dal Negro,Roberto W, Cazzola,Mario, Cicero,Arrigo F, Wedzicha,Jadwiga A, Calverley,Peter MA, Papi,Alberto, Page,Clive, Rogliani,Paola, Dal Negro,Roberto W, Cazzola,Mario, Cicero,Arrigo F, and Wedzicha,Jadwiga A

Abstract

Peter MA Calverley,1 Alberto Papi,2 Clive Page,3 Paola Rogliani,4 Roberto W Dal Negro,5 Mario Cazzola,4 Arrigo F Cicero,6 Jadwiga A Wedzicha7 1Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; 2Respiratory Medicine, University of Ferrara, Ferrara, Italy; 3Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College, London, UK; 4Respiratory Medicine Unit, Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy; 5National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy; 6Medical and Surgical Department, University of Bologna, Bologna, Italy; 7Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UKCorrespondence: Peter MA Calverley, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK, Tel +44 1515295886, Fax +44 1515295888, Email pmacal@liverpool.ac.ukPurpose: To explore the effect of erdosteine on COPD exacerbations, health-related quality of life (HRQoL), and subjectively assessed COPD severity.Patients and methods: This post-hoc analysis of the RESTORE study included participants with COPD and spirometrically moderate (GOLD 2; post-bronchodilator forced expiratory volume in 1 second [FEV1] 50‒79% predicted; n = 254), or severe airflow limitation (GOLD 3; post-bronchodilator FEV1 30‒49% predicted; n = 191) who received erdosteine 300 mg twice daily or placebo added to usual maintenance therapy for 12 months. Antibiotic and oral corticosteroid use was determined together with patient-reported HRQoL (St George’s Respiratory Questionnaire, SGRQ). Patient and physician subjective COPD severity scores (scale 0‒4) were rated at baseline, 6 and 12 months. Data were analyzed using descriptive statistics for exacerbation severity, COPD severity, and treatment group. Comparisons between treat

Published
2022

64. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]

Author

Calverley,Peter MA, Papi,Alberto, Page,Clive, Rogliani,Paola, Dal Negro,Roberto W, Cazzola,Mario, Cicero,Arrigo F, Wedzicha,Jadwiga A, Calverley,Peter MA, Papi,Alberto, Page,Clive, Rogliani,Paola, Dal Negro,Roberto W, Cazzola,Mario, Cicero,Arrigo F, and Wedzicha,Jadwiga A

Abstract

Calverley PMA, Papi A, Page C, et al. 2022;17:1909–1920. The authors wish to correct Figure 1 on page 1912 after it came to their attention an error had been made in the second box of the last row (moderate-to-severe exacerbations), the correct number is 7 not 36. The corrected Figure 1 is shown below:   The authors affirm that this error does not affect the results, discussion, and conclusions of the reported study and apologize for any inconvenience caused to the readers.

Published
2022

65. A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid

Author

Miravitlles,Marc, Verhamme,Katia, Calverley,Peter MA, Dreher,Michael, Bayer,Valentina, Gardev,Asparuh, de la Hoz,Alberto, Wedzicha,Jadwiga, Price,David, Miravitlles,Marc, Verhamme,Katia, Calverley,Peter MA, Dreher,Michael, Bayer,Valentina, Gardev,Asparuh, de la Hoz,Alberto, Wedzicha,Jadwiga, and Price,David

Abstract

Marc Miravitlles,1 Katia Verhamme,2 Peter MA Calverley,3 Michael Dreher,4 Valentina Bayer,5 Asparuh Gardev,6 Alberto de la Hoz,6 Jadwiga Wedzicha,7 David Price8,9 1Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 2Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands; 3Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK; 4Department of Pneumology and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany; 5Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 6Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; 7Head Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UK; 8Observational and Pragmatic Research Institute, Singapore; 9Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UKCorrespondence: Marc Miravitlles, Pneumology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), P° Vall d’Hebron 119-129, Barcelona, 08035, Spain, Email marcm@separ.esBackground: Recent studies report a lower mortality rate during treatment with long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA)/inhaled corticosteroid (ICS) versus LAMA/LABA in patients with symptomatic chronic obstructive pulmonary disease (COPD) and a history of exacerbations.Objective: We compared time to all-cause mortality with LAMA/LABA versus LAMA/LABA/ICS in patients with mild-to-very-severe COPD and a predominantly low exacerbation risk.Methods: Data were pooled from six randomized controlled trials (TONADO 1/2, DYNAGITO, WI

Published
2022

72. 0788 The effect of CPAP on quality of life in females with mild OSA: Post hoc analysis from the MERGE Randomised Trial

Author

Wimms, Alison, primary, Kelly, Julia, additional, Turnbull, Chris, additional, McMillan, Alison, additional, Craig, Sonia, additional, O’Reilly, John, additional, Nickol, Annabel, additional, Hedley, Emma, additional, Decker, Meredith, additional, Willes, Leslee, additional, Calverley, Peter, additional, Benjafield, Adam, additional, Stradling, John, additional, and Morrell, Mary, additional

Published
2022
Full Text
View/download PDF

76. Clinical significance and applications of oscillometry

Author

Kaminsky, David A., primary, Simpson, Shannon J., additional, Berger, Kenneth I., additional, Calverley, Peter, additional, de Melo, Pedro L., additional, Dandurand, Ronald, additional, Dellacà, Raffaele L., additional, Farah, Claude S., additional, Farré, Ramon, additional, Hall, Graham L., additional, Ioan, Iulia, additional, Irvin, Charles G., additional, Kaczka, David W., additional, King, Gregory G., additional, Kurosawa, Hajime, additional, Lombardi, Enrico, additional, Maksym, Geoffrey N., additional, Marchal, François, additional, Oostveen, Ellie, additional, Oppenheimer, Beno W., additional, Robinson, Paul D., additional, van den Berge, Maarten, additional, and Thamrin, Cindy, additional

Published
2022
Full Text
View/download PDF

78. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

Author

Martinez, Fernando J., primary, Agusti, Alvar, additional, Celli, Bartolome R., additional, Han, MeiLan K., additional, Allinson, James P., additional, Bhatt, Surya P., additional, Calverley, Peter, additional, Chotirmall, Sanjay H., additional, Chowdhury, Badrul, additional, Darken, Patrick, additional, Da Silva, Carla A., additional, Donaldson, Gavin, additional, Dorinsky, Paul, additional, Dransfield, Mark, additional, Faner, Rosa, additional, Halpin, David M., additional, Jones, Paul, additional, Krishnan, Jerry A., additional, Locantore, Nicholas, additional, Martinez, Fernando D., additional, Mullerova, Hana, additional, Price, David, additional, Rabe, Klaus F., additional, Reisner, Colin, additional, Singh, Dave, additional, Vestbo, Jørgen, additional, Vogelmeier, Claus F., additional, Wise, Robert A., additional, Tal-Singer, Ruth, additional, and Wedzicha, Jadwiga A., additional

Published
2022
Full Text
View/download PDF

82. Contributors

Author

Abdelmalak, Basem B., Abu-Omar, Yasir, Achilli, Felice, Adams, Sasha D., Aguirre-Bermeo, Hernán, Ahmed, Anas A., Aiello, Salvatore R., Akbari, Ayub, Alarcon, Louis H., Aldo, F. Luke, Alfaro-Maguyon, Maria Estela, Amin, Arpit, Angeli, Paolo, Annoni, Filippo, Antonelli, Massimo, Antongiorgi, Zarah D., Antoniadou, Anastasia, Arnaoutakis, Dean J., Astiz, Mark E., Azoulay, Élie, Baeza, Cristian, Baldisseri, Marie R., Balogh, Zsolt J., Banerjee, Arna, Bansal, Shweta, Barbier, François, Barjaktarevic, Igor, Bassin, Sarice L., Bastarache, Julie A., Baturin, Brian, Bausch, Daniel G., Beaulieu, Yanick, Beaver, Thomas, Bello, Giuseppe, Bellomo, Rinaldo, Bentea, Georgiana, Bermeo-Ovalle, Adriana C., Bernard, Gordon R., Berry, Cherisse, Bierens, Joost, Biffl, Walter L., Bihari, Shailesh, Bleck, Thomas P., Bledsoe, Thomas A., Bloch, Karen C., Boggild, Andrea K., Boncyk, Christina, Bond, Geoffrey J., Bradshaw, Michael J., Brakenridge, Scott, Branson, Richard D., Brimioulle, Serge, Brinson, Erika L., Brocca, Alessandra, Broman, Marcus Ewert, Brook, Itzhak, Brown, Christian J., Brunsvold, Melissa E., Buetti, Niccolò, Bulger, Eileen M., Cain, Christian, Calverley, Peter M.A., Cappelletty, Diane M., Casado-Arroyo, Ruben, Cecconi, Maurizio, Chae, June M., Chawla, Lakhmir S., Chan, Edward D., Chandrashekaran, Satish, Chandrika, Sharad, Chang, Wan-Tsu W., Chen, Dhruti P., Chopra, Amit, Christie, S. Ariane, Christman, John W., Cioci, Alessia C., Clark, Edward G., Cocanour, Christine, Cohen, Mitchell, Cole, Kelli A., Coleman, Lauren, Collins, Caitlin, Cook, Jared, Cooney, Robert N., Corbridge, Thomas, Cornely, Oliver A., Cortes-Lopez, Roxana, Crandall, Marie L., Čretnik, Andrej, Ashley, Chasen, Crouser, Elliott D., Navarro, Jovany Cruz, Curtis, J. Randall, Dalton, Heidi J., Darby, Joseph M., Davies, John D., Dayton, Orrin L., D’Costa, Rohit L., de Smet, Anne Marie G.A., Desai, Mehul A., Deutschman, Clifford, Dexter, Amanda M., Dhillon, Anahat, Muzio, Francesca Di, Diaz, Jose J., Jr., Dixon, Alexandra L., Doelken, Peter, Doidge, James, Dolinak, Joan, Donahoe, Michael, Driscoll, Ian R., Elhassan, Elwaleed A., Elie-Turenne, Marie Carmelle, Elmufdi, Firas, Ely, E. Wesley, Emlet, Lillian L., Emtiazjoo, Amir M., Ershoff, Brent, Estrera, Anthony L., Faggiano, Chiara, Falk, Ronald J., Farmer, Brenna, Farwell, Alan P., Feild, Carinda, Feller-Kopman, David, Hernandez, Samantha Fernandez, Ferrando-Vivas, Paloma, Ferrer, Miguel, Fisher, Caleb, Fishman, Guy, Flock, Jens, IV, Forman, Lisa, Fortune, Brett E., Freedman, Barry I., Fried, Elchanan, Gambino, Carmine, Gardiner, Dale, Gattinoni, Luciano, Gazmuri, Raúl J., Gehr, Todd W.B., Gerlach, Herwig, Ghobrial, R. Mark, Giamarellou, Helen, Ginsberg, Fredric, Gleason, Thomas G., Gorcsan, John, III, Gozal, Yaacov, Gradon, Jeremy D., Graves, Cornelia R., Greco, Massimiliano, Gregoretti, Cesare, Gropper, Michael A., Gubbins, Paul O., Gudzenko, Vadim, Gunnerson, Kyle J., Gunst, Jan, Gustafson, Kate S., Haase, Michael, Haase-Fielitz, Anja, Habib, Fahim, Harbrecht, Brian G., Harrison, David, Hill, Nicholas S., Hiremath, Swapnil, Hladik, Gerald A., Hoffman, Marcus K., Hollenberg, Steven M., Hoste, Eric A.J., Hsu, Albert, Huang, David T., Huber, Thomas S., Huggins, J. Terrill, Hamera, Joseph A., Ibrahim, Joseph Abdellatif, Isaac, Margaret L., Jabbour, Ibrahim I., Jacquerioz, Frederique A., Jadhav, Ashutosh, P., Jain, Sumeet V., Jansson, Paul S., Jeng, Eric I., Jozwiak, Mathieu, Kabrhel, Christopher, Kain, Taylor, Kaufman, David C., Kaynar, A. Murat, Kellum, John A., Kerwin, Andrew J., Kidd, Jason, Kilic, Arman, Kim, Donghee, Knudson, M. Margaret, Koehler, Philipp, Kollef, Marin H., Kormos, Robert L., Košir, Roman, Kotloff, Robert M., Kotzen, Elizabeth S., Koulenti, Despoina, Kratzert, Wolf Benjamin, Kumar, Anand, Langness, Simone, Lee, Jin, Leisman, Daniel, Leung, Angela M., Levin, Phillip D., Levy, Jerrold H., Levy, Mitchell M., Lewandowski, David C., Lewis, Anthony J., Bassi, Gianluigi Li, Liebman, Scott, Linas, Stuart L., Linefsky, Jason P., Lipman, Jeffrey, Lipsett, Pamela A., Lipshutz, Angela K.M., Loftus, Tyler J., Lopez-Magallon, Alejandro J., Lother, Sylvain, MacIntyre, Neil R., Magder, Sheldon, Maggiolini, Stefano, Mahajan, Aman, Maine, Rebecca, Maisch, Bernhard, Mancebo, Jordi, Mann, Henry J., Manocha, Sanjay, Margulies, Daniel R., Marik, Paul E., Marini, John J., Markan, Sandeep, Martinez-Camacho, Alvaro, Marx, William, Mayr, Florian B., Mazariegos, George V., McClave, Stephen A., McGloughlin, Steven A., McLean, Anna W., McMichael, Ali B.V., Meltzer, Joseph S., Merola, Raffaele, Messina, Antonio, Micek, Scott T., Mohammed, Subhan, Mohr, Alicia M., Monard, Celine, Monnet, Xavier, Montford, John, Moore, Ernest E., Moore, Frederick A., Moore, Hunter B., Moore, Laura J., Moore, Peter K., Mort, Thomas C., Motayar, Nasim, Muñoz, Ricardo A., Naber, Kurt G., Nadkarni, Vinay M., Nair, Girish B., Namias, Nicholas, Krishna, Vinay Narasimha, Nassikas, Nicholas J., New, Melissa L., Nguyen-Lee, Jennifer, Niccum, David E., Niederman, Michael S., Niven, Alexander S., Oddo, Mauro, Omer, Endashaw, Oostdijk, Evelien A.N., Opal, Steven M., Opdam, Helen I., Otto, Catherine M., Pannu, Sonal R., Parrillo, Joseph E., Pasero, Daniela, Patel, Rohit Pravin, Paterson, David L., Pavot, Arthur, Peitzman, Andrew B., Peluso, Lorenzo, Penoyer, Daleen Aragon, Pepe, Judith L., Pergakis, Melissa B., Peters, Steve G., Phelps, Mitch A., Picard, Fabien, Pilatz, Adrian, Piovesana, Giovanni, Pitisci, Lorenzo, Pollandt, Sebastian, Protti, Alessandro, Puyana, Juan Carlos, Puzio, Thaddeus J., Ra, Jin H., Raghu, Vikram K., Ramsingh, Davinder, Ranieri, V. Marco, Reynolds, Joshua C., Rimmelé, Thomas, Ristic, Arsen D., Rizzo, LTC Julie A., Robertson, Claudia S., Robinson, Christopher P., Robinson, Todd W., Roche-Campo, Ferran, Rodriguez, Ryan, Romito, Bryan T., Rosenthal, Martin D., Rowan, Daniel J., Rubenfeld, Gordon D., Rubin, Lewis J., Salgado, Juan C., Sambin, Pauline, Sánchez-de-Toledo, Joan, Santonocito, Cristina, Sappington, Penny Lynn, Sartelli, Massimo, Savelieva, Irina, Schott, Christopher K., Schouten, Jeroen A., Schreiber, Martin A., Schulman, Carl, See, Emily J., Seese, Laura M., Selickman, John, Sempsrott, Justin, Sethuraman, Kinjal N., Shemie, Sam D., Shiloh, Ariel L., Silvis, Jennifer L., Singer, Pierre, Singh, Sumit P., Sreedharan, Roshni, Steinberg, Alexis, Streichenberger, Antoine, Szpilman, David, Szychowiak, Piotr, Taccone, Fabio Silvio, Tanaka, Akiko, Tanner, Colby, Tawfik, Pierre N., Teboul, Jean-Louis, Teitelbaum, Isaac, Terragni, Pierpaolo, Thom, Stephen R., Thompson, Ashley, Timsit, Jean-Francois, Tisherman, Samuel A., Todd, S. Rob, Tolwani, Ashita J., Tonetti, Tommaso, Tonon, Marta, Torres, Antoni, Toscano, Nicole C., Tsai, Lillian L., Turner, Cody D., Tyndall, J. Adrian, Tzeng, Edith, Berghe, Greet Van den, van Zanten, Arthur R.H., Vanommeslaeghe, Floris, Vanzant, Erin L., Venkataraman, Ramesh, Verdiner, Ricardo E., Vincent, Jean-Louis, Wagenlehner, Florian M.E., Walker, Paul Phillip, Walley, Keith, Walter, James, Wang, Tisha, Wang, Kevin K.W., Ward, Nicholas S., Ware, Lorraine B., Warrillow, Stephen, Watson, Gregory A., Wechsler, Lawrence R., Weissman, Charles, Wille, Keith M., Wunderink, Richard G., Yang, Zhihui, Yende, Sachin, Yi, Stephanie Grace, Young, Paul, Zeitler, Evan, and Zhao, Frank Z.

Published
2024
Full Text
View/download PDF

83. α;1-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts

Author

Sørheim, Inga-Cecilie, Bakke, Per, Gulsvik, Amund, Pillai, Sreekumar G., Johannessen, Ane, Gaarder, Per I., Campbell, Edward J., Agustí, Alvar, Calverley, Peter M.A., Donner, Claudio F., Make, Barry J., Rennard, Stephen I., Vestbo, Jørgen, Wouters, Emiel F.M., Paré, Peter D., Levy, Robert D., Coxson, Harvey O., Lomas, David A., Hersh, Craig P., and Silverman, Edwin K.

Published
2010
Full Text
View/download PDF

85. The effects of cancer therapies on physical fitness before oesophagogastric cancer surgery: a prospective, blinded, multi-centre, observational, cohort study [version 1; peer review: 2 approved]

Author

West, Malcolm A, Anastasiou, Zachos, Ambler, Gareth, Loughney, Lisa, Mythen, Michael G, Owen, Thomas, Danjoux, Gerard, Levett, Denny Z H, Calverley, Peter M A, Kelly, Jamie J, Jack, Sandy, and Grocott, Michael P W

Abstract

Background: neoadjuvant cancer treatment is associated with improved survival following major oesophagogastric cancer surgery. The impact of neoadjuvant chemo/chemoradiotherapy on physical fitness and operative outcomes is however unclear. This study aims to investigate the impact of neoadjuvant chemo/chemoradiotherapy on fitness and post-operative mortality.Methods: patients with oesophagogastric cancer scheduled for chemo/chemoradiotherapy and surgery were recruited to a prospective, blinded, multi-centre, observational cohort study. Primary outcomes were changes in fitness with chemo/chemoradiotherapy, measured using cardiopulmonary exercise testing and its association with mortality one-year after surgery. Patients were followed up for re-admission at 30-days, in-hospital morbidity and quality of life (exploratory outcomes).Results: in total, 384 patients were screened, 217 met the inclusion criteria, 160 consented and 159 were included (72% male, mean age 65 years). A total of 132 patients (83%) underwent chemo/chemoradiotherapy, 109 (71%) underwent chemo/chemoradiotherapy and two exercise tests, 100 (63%) completed surgery and follow-up. A significant decline in oxygen uptake at anaerobic threshold and oxygen uptake peak was observed following chemo/chemoradiotherapy: -1.25ml.kg-1.min-1 (-1.80 to - 0.69) and -3.02ml.kg-1.min-1 (-3.85 to -2.20); pConclusion: chemo/chemoradiotherapy prior to oesophagogastric cancer surgery reduced physical fitness. Lower baseline fitness was associated with reduced overall survival at one-year. Careful consideration of fitness prior to chemo/chemoradiotherapy and surgery is urgently needed.

Published
2021

94. One-year change in health status and subsequent outcomes in COPD

Author

Wilke, Sarah, Jones, Paul W, Müllerova, H, Vestbo, Jørgen, Tal-Singer, Ruth, Franssen, Frits ME, Agusti, Alvar, Bakke, Per, Calverley, Peter M, Coxson, Harvey O, Crim, Courtney, Edwards, Lisa D, Lomas, David A, MacNee, William, Rennard, Stephen I, Yates, Julie C, Wouters, Emiel FM, and Spruit, Martijn A

Published
2015
Full Text
View/download PDF

95. Hospitalized Exacerbations of COPD: Risk Factors and Outcomes in the ECLIPSE Cohort

Author

Müllerova, Hana, Maselli, Diego J., Locantore, Nicholas, Vestbo, Jørgen, Hurst, John R., Wedzicha, Jadwiga A., Bakke, Per, Agusti, Alvar, Anzueto, Antonio, Ivanov, Yavor, Kostov, Kosta, Bourbeau, Jean, Fitzgerald, Mark, Hernández, Paul, Killian, Kieran, Levy, Robert, Maltais, Francois, O´Donnell, Denis, Krepelka, Jan, Vestbo, Jørgen, Wouters, Emiel F. M., Quinn, Dean, Bakke, Per, Kosnik, Mitja, Agusti, Alvar, Feschenko, Yuri, Gavrisyuk, Volodymyr, Yashina, Lyudmila, MacNee, William, Singh, S. David, Wedzicha, Jadwiga, Anzueto, Antonio, Braman, Sidney, Casaburi, Richard, Celli, Bart, Giessel, Glenn, Gotfried, Mark, Greenwald, Gary, Hanania, Nicola, Mahler, Don, Make, Barry, Rennard, Stephen, Rochester, Carolyn, Scanlon, Paul, Schuller, Dan, Sciurba, Frank, Sharafkhaneh, Amir, Siler, Thomas, Silverman, Edwin, Wanner, Adam, Wise, Robert, Zu Wallack, Richard, Bakke, Per, Coxson, Harvey, Edwards, Lisa, Lomas, David, MacNee, William, Silverman, Edwin, Tal-Singer, Ruth, Vestbo, Jørgen, Yates, Julie, Agusti, Alvar, Calverley, Peter, Celli, Bartolome, Crim, Courtney, Miller, Bruce, MacNee, William, Rennard, Stephen, Tal-Singer, Ruth, and Wouters, Emiel

Published
2015
Full Text
View/download PDF

96. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease

Author

Celli, Bartolome R., Decramer, Marc, Wedzicha, Jadwiga A., Wilson, Kevin C., Agustí, Alvar, Criner, Gerard J., MacNee, William, Make, Barry J., Rennard, Stephen I., Stockley, Robert A., Vogelmeier, Claus, Anzueto, Antonio, Au, David H., Barnes, Peter J., Burgel, Pierre-Regis, Calverley, Peter M., Casanova, Ciro, Clini, Enrico M., Cooper, Christopher B., Coxson, Harvey O., Dusser, Daniel J., Fabbri, Leonardo M., Fahy, Bonnie, Ferguson, Gary T., Fisher, Andrew, Fletcher, Monica J., Hayot, Maurice, Hurst, John R., Jones, Paul W., Mahler, Donald A., Maltais, François, Mannino, David M., Martinez, Fernando J., Miravitlles, Marc, Meek, Paula M., Papi, Alberto, Rabe, Klaus F., Roche, Nicolas, Sciurba, Frank C., Sethi, Sanjay, Siafakas, Nikos, Sin, Don D., Soriano, Joan B., Stoller, James K., Tashkin, Donald P., Troosters, Thierry, Verleden, Geert M., Verschakelen, Johny, Vestbo, Jorgen, Walsh, John W., Washko, George R., Wise, Robert A., Wouters, Emiel F. M., and ZuWallack, Richard L.

Published
2015
Full Text
View/download PDF

97. Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis

Author

Rennard, Stephen I., Locantore, Nicholas, Delafont, Bruno, Tal-Singer, Ruth, Silverman, Edwin K., Vestbo, Jørgen, Miller, Bruce E., Bakke, Per, Celli, Bartolomé, Calverley, Peter M. A., Coxson, Harvey, Crim, Courtney, Edwards, Lisa D., Lomas, David A., MacNee, William, Wouters, Emiel F. M., Yates, Julie C., Coca, Ignacio, and Agustí, Alvar

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results